Drug
HS 10504
HS 10504: highest development phase Phase 1, developed by Hansoh Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-10504 NCT07770217 | Phase 1 | Healthy Participants |
| HS-10504 NCT06461156 | Phase 1 | Locally Advanced or Metastatic NSCLC |
Latest
No recent events.
Follow HS 10504 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.